JENNIFER BLACKERBY: Open Payments
NPI 1144933367 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,995 in 114 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $846 · 2025 $2,995
Food & beverage: $2,936Education: $59
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $654 |
| Regeneron Healthcare Solutions, Inc. | 15 | $420 |
| CSL Behring | 16 | $369 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $306 |
| GlaxoSmithKline, LLC. | 14 | $199 |
| Pharming Healthcare, Inc. | 3 | $192 |
| Verona Pharma, Inc. | 6 | $160 |
| Blueprint Medicines Corporation | 4 | $119 |
| Organon LLC | 6 | $110 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, Andembry, RUCONEST, Ohtuvayre, AIRSUPRA, NUCALA.
Industry payments across TX — which companies pay providers there.
